Leveraging intratumoral probiotics for pancreatic cancer immunotherapy via xenophagy
Authors:
- 7 March 2026
- journal article
- Published by Elsevier in Cell Host & Microbe
- Vol. 34 (4) , 657-671.e7
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
This publication has 48 references indexed in Scilit:
- Long-distance microbial mechanisms impacting cancer immunosurveillanceImmunity, 2024
- Nanodrug-bacteria conjugates-mediated oncogenic collagen depletion enhances immune checkpoint blockade therapy against pancreatic cancerMed, 2024
- Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies?Pharmaceutical Research, 2019
- Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer OutcomesCell, 2019
- Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosisNature Cell Biology, 2016
- Sirolimus and everolimus in kidney transplantationDrug Discovery Today, 2015
- Development of Orthotopic Pancreatic Tumor Mouse Models2012
- Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cellsNature Medicine, 2009
- Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 bindingNature Medicine, 2000
- Peptide length preferences for rat and mouse MHC class I molecules using random peptide librariesEuropean Journal of Immunology, 1998